FYARRO
Active substance: sirolimus
INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION · SIROLIMUS 5 mg/mL
United StatesActive
Marketing holder: Aadi Bioscience, Inc.
Verified 2026-10-09 · openFDA NDC
Analogues in other countries- Source: openFDA NDC
- Countries with the substance registered: 3
- SIROLIMUS · 5 mg/mL
Products with the same active substance registered in other countries.
| Country | Products |
|---|---|
| RU 5 |
|
| EU 3 |
Control by country
- Russiaprescription only
Source: GRLS (Russian state register) · record 01a120c3-d17e-7016-b64d-884b86e97f7a,01a120c3-daf1-7094-bce2-64d0d3745820,01a120c6-4cfd-717b-9e3c-8b590d4ab834,01a120c6-84c1-7cbb-993e-ebf349611da9;count=4 · valid from 2026-10-09 · verified 2026-10-09
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-2f11-7c1b-a72f-44533bc85422,01a1208c-ac9c-7d3e-8a87-99c18331a987,01a1208d-8db6-7aa4-a66b-0f225af0d48f,01a1208d-8eef-701b-9e60-7cc82b9002d8,01a1208d-cbef-7244-b070-c5a953411da8;count=39 · valid from 2026-10-09 · verified 2026-10-09
- Registration number
- 80803-153
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- INTRAVENOUS
- product · openFDA NDC · 80803-153 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 80803-153 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 80803-153 · Verified 2026-10-09 · open in source